Palantir vs. Ginkgo: The Surprising Biosecurity Battle Investors Can’t Ignore
Palantir (NYSE:PLTR) and Ginkgo Bioworks (NYSE:DNA) are not chasing the same opportunity. One is a high-expectation AI software leader tied to government adoption. The other is a beaten-down biology infrastructure bet. That gap creates the real investor question: where does the biological firewall create the most value? Stock prices used were the market prices of … Read more
